Juan Manuel Moreno

Juan Manuel Moreno

Auto-generated profile, based on publicly available information

Juan Manuel Moreno

Nephrology Service, Virgen de las Nieves University Hospital, Granada, Spain

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in European Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
Félix VargasFélix Vargas
Félix Vargas
JMJuan Manuel Moreno
Juan Manuel Moreno
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
AOAntonio Osuna
Antonio Osuna
Joaquin Garcia-EstañJoaquin Garcia-Estañ
Joaquin Garcia-Estañ
This review focuses on the effects of thyroid hormones in vascular and renal systems. Special emphasis is given to the mechanisms by which thyroid hormones affect the regulation of body fluids, vascular resistance and, ultimately, blood pressure. Vascular function is markedly affected by thyroid hormones that produce changes in vascular reactivity and endothelial function in hyper- and hypothyroidism. The hypothyroid state is accompanied by a marked decrease in sensitivity to vasoconstrictors, especially to sympathetic agonists, alteration that may play a role in the reduced blood pressure of hypothyroid rats, as well as in the preventive effects of hypothyroidism on experimental hypertension. Moreover, in hypothyroid rats, the endothelium-dependent and nitric oxide donors vasodilation is reduced. Conversely, the vessels from hyperthyroid rats showed an increased endothelium-dependent responsiveness that may be secondary to the shear-stress induced by the hyperdynamic circulation, and that may contribute to the reduced vascular resistance characteristic of this disease. Thyroid hormones also have important effects in the kidney, affecting renal growth, renal haemodynamics, and salt and water metabolism. In hyperthyroidism, there is a resetting of the pressure-natriuresis relationship related to hyperactivity of the reninangiotensin system, which contributes to the arterial hypertension associated with this endocrine disease. Moreover, thyroid hormones affect the development and/or maintenance of various forms of arterial hypertension. This review also describes recent advances in our understanding of thyroid hormone action on nitric oxide and oxidative stress in the regulation of cardiovascular and renal function and in the long-term control of blood pressure.

27 April 2008 in Transplantation
Verified
Journal Article
Closed access
EPEsteban Porrini
Esteban Porrini
JMJose Manuel Moreno
Jose Manuel Moreno
AOAntonio Osuna
Antonio Osuna
RBRocio Benitez
Rocio Benitez
ILIldefonso Lampreabe
Ildefonso Lampreabe
ATArmando Torres
Armando Torres
Tacrolimus-based immunosuppression, the most widely used regimen in kidney transplantation, increases the risk of new onset diabetes after transplantation (NODAT). However, the prevalence, evolution and risk factors of different prediabetic alterations: impaired fasting glucose, impaired glucose tolerance, and provisional diabetes, have not been established. In this multicenter and prospective study we evaluated 154 nondiabetic kidney transplant recipients receiving tacrolimus, mycophenolate mofetil and low dose steroids. An oral glucose tolerance test was performed 3 and 12 months after transplantation and prediabetes was defined by American Diabetes Association criteria. Prediabetes was highly prevalent and showed little variation between 3 and 12 months (36% and 33%, respectively). Impaired glucose tolerance was the most frequent abnormality observed (23% and 25%, respectively) observed. In addition, 20% of recipients showed NODAT by 1 year. Multivariate analysis showed that age (odds ratio [OR]: 1.07, 95% confidence interval [CI]: 1.004–1.14), pretransplant body mass index (OR: 1.3, CI: 1.09–1.6) and triglyceride/high density lipoprotein-cholesterol ratio, a marker of insulin resistance, (OR: 1.4, CI: 1.05–1.9) were independent risk factors for prediabetes. One in two recipients with tacrolimus-based immunosuppresion showed prediabetes or NODAT by 1 year posttransplantation when properly investigated. Older age and high pretransplant body mass index and triglyceride/high density lipoprotein-cholesterol ratio were risk factors for prediabetes. These findings may help applying early interventions to prevent the disorder.

10 November 2009 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Miguel RomeroMiguel Romero
Miguel Romero
RJRosario Jiménez-Moleon
Rosario Jiménez-Moleon
BHBelén Hurtado
Belén Hurtado
JMJuan Manuel Moreno
Juan Manuel Moreno
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
Juan DuarteJuan Duarte
Juan Duarte

1 April 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
JMJ.M. Moreno
J.M. Moreno
MRM.C. Ruiz
M.C. Ruiz
NRN. Ruiz
N. Ruiz
IGI. Gomez
I. Gomez
FVF. Vargas
F. Vargas
AOA. Osuna
A. Osuna

19 February 2004 in Experimental Physiology
Verified
Journal Article
Open access
PDF file
Juan SainzJuan Sainz
Juan Sainz
AOAntonio Osuna
Antonio Osuna
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
JCJuan De Dios Luna del Castillo
Juan De Dios Luna del Castillo
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
Félix VargasFélix Vargas
Félix Vargas
In this study we have evaluated the influence of sex, gonadectomy and sex hormones on the development of l‐NAME‐induced hypertension in the rat, focusing our investigation on blood pressure (BP), plasma renin activity (PRA), cardiac hypertrophy and proteinuria. Three experiments were performed to investigate: (i) the influence of sex on the development of l‐NAME‐induced hypertension; (ii) the effects of gonadectomy on the dimorphism of l‐NAME‐induced hypertension; and (iii) the effects of testosterone in ovariectomized female and of 17β‐oestradiol in orchidectomized male rats. Male l‐NAME‐treated rats had higher BP values than females. Orchidectomy of l‐NAME‐treated rats reduced BP to the levels of females and ovariectomy did not affect hypertension in females. Oestrogenized and orchidectomized males had a BP level similar to intact female l‐NAME‐treated rats. However, androgenization and ovariectomy did not change BP in female l‐NAME‐treated rats. PRA was greater in intact male l‐NAME hypertensive rats than in female rats, and gonadectomy protected against the increase in PRA such that PRA was similar among all the groups. Intact female hypertensive rats showed significantly greater ventricular hypertrophy compared with male hypertensive rats. Male l‐NAME hypertensive rats had increased proteinuria that was not present in female rats. Moreover, testosterone increased proteinuria in males and females regardless of the BP level. Male l‐NAME‐treated rats developed higher BP, PRA and proteinuria than female rats, but were more resistant to the development of cardiac hypertrophy. The higher PRA of male l‐NAME‐treated rats might be involved in the sex‐dependent dimorphism of this model of hypertension.

1 February 2004 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Rosemary WangensteenRosemary Wangensteen
Rosemary Wangensteen
JMJuan Manuel Moreno
Juan Manuel Moreno
Juan SainzJuan Sainz
Juan Sainz
Isabel Rodríguez-GómezIsabel Rodríguez-Gómez
Isabel Rodríguez-Gómez
VCVirginia Chamorro
Virginia Chamorro
FVFélix Vargas
Félix Vargas